NCT03702348

Brief Summary

Common symptoms of chikungunya fever are persistent arthritis and arthralgia, such symptoms can lead to impairment in functionality. The objective of this study is to evaluate the efficacy of a resistance exercise protocol on the functionality of individuals with chronic musculoskeletal manifestations of Chikungunya fever. Quality of life, number of painful joints, intensity of pain, number of recurrence of exacerbation and thermography are secondary outcomes that will also be evaluated. The protocol uses elastic resistance to strengthen muscle groups that stabilize the main joints affected by Chikungunya Fever. The sessions will be 2 times a week for 12 weeks. The control group will not be submitted to the intervention during the 12 weeks, being contacted through telephone calls. After the reevaluation at the end of the 12 weeks the control group will perform the same protocol. The sample will be characterized and the effect size and the mean difference will be calculated. Intention-to-treat analysis and rate of adherence will also be calculated.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at P50-P75 for early_phase_1

Timeline
Completed

Started Jul 2018

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 9, 2018

Completed
14 days until next milestone

Study Start

First participant enrolled

July 23, 2018

Completed
3 months until next milestone

First Posted

Study publicly available on registry

October 11, 2018

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2019

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2019

Completed
Last Updated

September 27, 2019

Status Verified

September 1, 2019

Enrollment Period

1.2 years

First QC Date

July 9, 2018

Last Update Submit

September 25, 2019

Conditions

Outcome Measures

Primary Outcomes (4)

  • Change in functionality through a walk test

    Performance in seconds of the 40m Fast-paced Walk Test, the longer the time in seconds, the worse the outcome. The normative values for women between 50´s and 60´s age range are 19,90 to 22,60 seconds, and for men in the same age range between 19,32 and 20,73 seconds.

    Assessed before intervention, in 6 weeks and after the 12-week intervention

  • Change in functionality through a stair climb test

    Performance in seconds of the 4 step stair climb test, the longer the time in seconds, the worse the outcome. The normative values mean for healthy women is 10.22 seconds and healthy men is 8.72 seconds

    Assessed before intervention, in 6 weeks and after the 12-week intervention

  • Change in functionality through a chair stand test

    Performance in number of time the patient stands in the 30-Second Chair Stand Test, the higher the number of the better the outcome, the mean for women in the 60´s age range is from 11 to 17 times and for men in the same age range is from 12 to 19 times

    Assessed before intervention, in 6 weeks and after the 12-week intervention

  • Change in functionality of upper limbs

    Function of upper limb trough specific score of the Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire with 30 items with responses range from 1(not limited) to 5 (extremely limited) and two optional sections, responses are used to calculate a scale score ranging from 0 (no disability) to 100 (most severe disability)

    Assessed before intervention, in 6 weeks and after the 12-week intervention

Secondary Outcomes (8)

  • Change of score on the Medical Outcomes Study 36 - Item Short - Form Health Survey questionnaire

    assessed before intervention, in 6 weeks and after the 12-week intervention

  • Change in the intensity of pain: VAS

    assessed in every intervention day (twice a week for 12 weeks)

  • Change in the number of painful joints

    assessed before intervention, in 6 weeks and after the 12-week intervention

  • Change in the number of exacerbation recurrences

    assessed through the 12-week intervention period

  • Change in temperature of areas of interest (joints)

    assessed before intervention, in 6 weeks and after the 12-week intervention

  • +3 more secondary outcomes

Study Arms (2)

Resistance exercise group

EXPERIMENTAL

Progressive resistance exercise protocol with elastic resistance to strengthen the muscle groups that stabilize the main joints affected by Chikungunya Fever. The sessions will be 2 times a week for 12 weeks.

Other: Resistance exercise

Control group

NO INTERVENTION

No intervention during the 12 weeks, being contacted through telephone calls. After the reevaluation at the end of the 12 weeks, this group will perform the same protocol as the experimental group

Interventions

Protocol with 5min warm-up exercise and 8 exercises that progress in positioning and resistance based on maximum repetition test. The exercises strengthen both the lower and upper limbs and are intended to simulate activities such as sitting and standing up, climbing stairs, picking up weight ...

Also known as: Resistance exercise protocol
Resistance exercise group

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of Chikungunya fever for more than three months
  • Present musculoskeletal symptoms after infection (eg, arthritis or arthralgia)

You may not qualify if:

  • Cognitive deficit that compromises the understanding and accomplishment of the protocol (MiniMental\<24);
  • Self-reported disease that contraindicates the performance of research procedures (eg, unstable angina);
  • Self-reported diagnosis of neurological disease;
  • Prior self-reported diagnosis of other inflammatory or autoimmune rheumatic diseases or fibromyalgia;
  • Pregnancy;
  • Physical impairment that prevents arrival to the research site or execution of the exercises (eg, use of walking devices);
  • Execution of other physiotherapeutic treatments during the research period;
  • Regular practice of physical exercises in other places during the period of participation in the research.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clínica Escola de Fisioterapia - UFPE

Recife, Pernambuco, 50740-560, Brazil

Location

MeSH Terms

Conditions

Chikungunya Fever

Interventions

Resistance Training

Condition Hierarchy (Ancestors)

Alphavirus InfectionsArbovirus InfectionsVector Borne DiseasesInfectionsMosquito-Borne DiseasesVirus DiseasesTogaviridae InfectionsRNA Virus Infections

Intervention Hierarchy (Ancestors)

Exercise TherapyRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy ModalitiesPhysical Conditioning, HumanExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

July 9, 2018

First Posted

October 11, 2018

Study Start

July 23, 2018

Primary Completion

October 1, 2019

Study Completion

November 1, 2019

Last Updated

September 27, 2019

Record last verified: 2019-09

Locations